Pill-Based Obesity Device From Gelesis Gets Financing
This article was originally published in The Pink Sheet Daily
Executive Summary
Startup Gelesis Inc. announced a $12 million funding round to support an FDA study for its Gelesis 100 “smart pill” as a tool to induce feelings of hunger and satiety.
You may also be interested in...
McKesson Tagged With Rare Class I Recall For Clinical Decision Support Software
McKesson Corp.’s McKesson Anesthesia Care clinical decision support system was the subject of a class I recall, a rarity in the health information technology sector that could offer insights into FDA oversight of the space going forward.
Big Tech Firms Target Health Care Space With Cheap Sensors In Smartphones
Recent activities by three smartphone giants point to a potential future where the phone itself more frequently serves as a monitoring or diagnosing device, in place of external sensors. If the trend rolls on, it could have important implications for the mobile health sector.
Big Tech Firms Target Health Care Space With Cheap Sensors In Smartphones
Recent activities by three smartphone giants point to a potential future where the phone itself more frequently serves as a monitoring or diagnosing device, in place of external sensors. If the trend rolls on, it could have important implications for the mobile health sector.